Healthcare -
Biotechnology - NASDAQ - US
$ 46.98
1.8 %
$ 3.62 B
Market Cap
-7.91
P/E
PTCT - COST OF REVENUE
Cost of Revenue PTCT - PTC Therapeutics, Inc.
65.5 M
LAST VALUE
42.33%
2 YEAR CAGR
38.89%
5 YEAR CAGR
1.78%
10 YEAR CAGR